sb 203580 has been researched along with lactic acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (lactic acid) | Trials (lactic acid) | Recent Studies (post-2010) (lactic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 46,263 | 3,349 | 19,053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fu, XB; Sun, TZ; Xu, JG; Zhao, JY; Zheng, SY | 1 |
1 other study(ies) available for sb 203580 and lactic acid
| Article | Year |
|---|---|
Inhibition of p38 mitogen-activated protein kinase may decrease intestinal epithelial cell apoptosis and improve intestinal epithelial barrier function after ischemia- reperfusion injury.
Topics: Animals; Apoptosis; Biological Transport; Enzyme Inhibitors; Imidazoles; Intestinal Mucosa; Lactic Acid; Male; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar; Reperfusion Injury | 2005 |